Calcium treatment for bladder tumors using electric pulses
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests a new approach that uses calcium and electric pulses to destroy bladder tumor cells. It is for people who cannot have standard surgery or radiation, or who have not responded to other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a type of bladder cancer called urothelial carcinoma.
- You are not able to have your bladder removed (cystectomy) or radiation therapy.
- You have tumors that are high-risk and do not invade the muscle layer, as decided by your doctors.
- You are generally well enough to have general anesthesia and a life expectancy of at least 3 months.
- If you are of childbearing age and sexually active, you must use contraception during the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a new treatment for advanced bladder cancer (urothelial carcinoma) using two drugs, enfortumab vedotin and pembrolizumab, which help the immune system fight cancer. The study also tests a supportive therapy called Neuridase to help prevent or reduce nerve damage (peripheral neuropathy) that can be a side effect of the cancer treatment.
This trial tests a combination of two drugs (enfortumab vedotin and pembrolizumab) given before surgery to shrink or eliminate bladder or upper tract cancer. The goal is to see if this approach reduces the chance of cancer coming back and improves outcomes.
This trial tests a procedure called therapeutic plasma exchange (TPE) combined with the drugs enfortumab vedotin and pembrolizumab for people with advanced bladder cancer that has stopped responding to standard treatments. The goal is to see if TPE helps the drugs work better.
This trial tests a new type of radiation therapy that adjusts to your body's changes during treatment. It aims to reduce side effects and improve accuracy for people with bladder cancer.
This trial tests a new treatment that uses your own immune cells, called CAR-NK cells, modified to attack two proteins (Nectin-4 and HER2) often found on bladder cancer cells. It is for people whose cancer has spread or cannot be removed by surgery and has not responded to standard treatments like chemotherapy or immunotherapy.
This trial tests whether radiation therapy (high-energy beams to kill cancer cells) can be a good treatment for bladder cancer that hasn't gone away after BCG therapy, offering an alternative to surgery to remove the bladder. It aims to see if this approach can control the cancer while possibly preserving your bladder.
Hear when a new Bladder Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.